Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Emanuele F. Osimo"'
Autor:
Wing Tse, Golam M. Khandaker, Huiquan Zhou, Hao Luo, Wai Ching Yan, Man Wah Siu, Lap Tak Poon, Edwin Ho Ming Lee, Qingpeng Zhang, Rachel Upthegrove, Emanuele F. Osimo, Benjamin I. Perry, Sherry Kit Wa Chan
Publikováno v:
The Lancet Regional Health. Western Pacific, Vol 47, Iss , Pp 101089- (2024)
Summary: Background: Metabolic syndrome (MetS) is common following first-episode psychosis (FEP), contributing to substantial morbidity and mortality. The Psychosis Metabolic Risk Calculator (PsyMetRiC), a risk prediction algorithm for MetS following
Externí odkaz:
https://doaj.org/article/1eceb9313fdf453ab4018f6244637f98
Autor:
Emanuele F. Osimo, Mark Sweeney, Antonio de Marvao, Alaine Berry, Ben Statton, Benjamin I. Perry, Toby Pillinger, Thomas Whitehurst, Stuart A. Cook, Declan P. O’Regan, E. Louise Thomas, Oliver D. Howes
Publikováno v:
Translational Psychiatry, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Cardiovascular diseases are the leading cause of death in schizophrenia. Patients with schizophrenia show evidence of concentric cardiac remodelling (CCR), defined as an increase in left-ventricular mass over end-diastolic volumes. CCR is a
Externí odkaz:
https://doaj.org/article/5831c44a2ba848ddabcf4d09d8406aba
Autor:
Benjamin I. Perry, Frederik Vandenberghe, Nathalia Garrido-Torres, Emanuele F. Osimo, Marianna Piras, Javier Vazquez-Bourgon, Rachel Upthegrove, Claire Grosu, Victor Ortiz-Garcia De La Foz, Peter B. Jones, Nermine Laaboub, Miguel Ruiz-Veguilla, Jan Stochl, Celine Dubath, Manuel Canal-Rivero, Pavan Mallikarjun, Aurélie Reymond-Delacrétaz, Nicolas Ansermot, Emilio Fernandez-Egea, Severine Crettol, Franziska Gamma, Kerstin J. Plessen, Philippe Conus, Golam M. Khandaker, Graham K. Murray, Chin B. Eap, Benedicto Crespo-Facorro
Publikováno v:
The Lancet Regional Health. Europe, Vol 22, Iss , Pp 100493- (2022)
Summary: Background: Cardiometabolic dysfunction is common in young people with psychosis. Recently, the Psychosis Metabolic Risk Calculator (PsyMetRiC) was developed and externally validated in the UK, predicting up-to six-year risk of metabolic syn
Externí odkaz:
https://doaj.org/article/6f4f9f85cd3b4ce5b59625bb3d5e11b3
Publikováno v:
npj Schizophrenia, Vol 8, Iss 1, Pp 1-3 (2022)
Abstract People with schizophrenia show higher risk for abdominal obesity than the general population, which could contribute to excess mortality. However, it is unclear whether this is driven by alterations in abdominal fat partitioning. Here, we te
Externí odkaz:
https://doaj.org/article/29e8b613005144c7af3e9f6a865bd5b6
Autor:
Emanuele F. Osimo, Luke Baxter, Jan Stochl, Benjamin I. Perry, Stephen A. Metcalf, Setor K. Kunutsor, Jari A. Laukkanen, Marie Kim Wium-Andersen, Peter B. Jones, Golam M. Khandaker
Publikováno v:
npj Schizophrenia, Vol 7, Iss 1, Pp 1-9 (2021)
Abstract Meta-analyses of cross-sectional studies suggest that patients with psychosis have higher circulating levels of C-reactive protein (CRP) compared with healthy controls; however, cause and effect is unclear. We examined the prospective associ
Externí odkaz:
https://doaj.org/article/34fac0cb5f19474f996fc76e386941c2
Publikováno v:
Comprehensive Psychiatry, Vol 96, Iss , Pp - (2020)
Background: Meta-analyses confirm increased circulating C-reactive protein (CRP) levels in depression. Longitudinal studies have linked one-off measurements of CRP at baseline with increased risk of developing depressive symptoms subsequently at foll
Externí odkaz:
https://doaj.org/article/24256bfed1ea424f8a5941c19cc5ad35
Autor:
Toby Pillinger, Emanuele F Osimo, Antonio de Marvao, Mit Shah, Catherine Francis, Jian Huang, Enrico D'Ambrosio, Joseph Firth, Matthew M Nour, Robert A McCutcheon, Antonio F Pardiñas, Paul M Matthews, Declan P O'Regan, Oliver D Howes
Publikováno v:
Pillinger, T, Osimo, EF, de, M A, D'Ambrosio, E, Firth, J, Nour, MM, McCutcheon, RA, Pardiñas, AF, O'Regan, DP & Howes, OD 2023, ' Effect of polygenic risk for schizophrenia on cardiac structure and function: a UK Biobank observational study. ', The lancet. Psychiatry, vol. 10, no. 2, pp. 98-107 . https://doi.org/10.1016/s2215-0366(22)00403-5
Background:Cardiovascular disease is a major cause of excess mortality in people with schizophrenia. Several factors are responsible, including lifestyle and metabolic effects of antipsychotics. However, variations in cardiac structure and function a
Autor:
Emanuele F. Osimo, Benjamin I. Perry, Pavan Mallikarjun, Megan Pritchard, Jonathan Lewis, Asia Katunda, Graham K. Murray, Jesus Perez, Peter B. Jones, Rudolf N. Cardinal, Oliver D. Howes, Rachel Upthegrove, Golam M. Khandaker
Funder: MQ: Transforming Mental Health; Grant(s): MQDS17/40
Around a quarter of people who experience a first episode of psychosis (FEP) will develop treatment-resistant schizophrenia (TRS), but there are currently no established clinically usef
Around a quarter of people who experience a first episode of psychosis (FEP) will develop treatment-resistant schizophrenia (TRS), but there are currently no established clinically usef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2ffc1367c38013af4430cacee9bdc67
Publikováno v:
The Journal of Mental Health Training, Education and Practice. 16:410-417
Purpose In previous research, personality and exposure to psychiatry were independently shown to shape medical students attitudes towards psychiatry (ATP). This paper aims to investigate the role of psychiatry placements and personality types on medi
Funder: NIHR Imperial Biomedical Research Centre
The antipsychotic clozapine is known to have immune-modulating effects. Clozapine treatment has been reported to be associated with increased risk of COVID-19 infection. However, it remains unclea
The antipsychotic clozapine is known to have immune-modulating effects. Clozapine treatment has been reported to be associated with increased risk of COVID-19 infection. However, it remains unclea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8362317b01f3b21d977c606028f81de4